CoChat

A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Abstract

GOALS: To evaluate the effectiveness of psychiatric counseling in reducing the rate of development of psychiatric side effects of antiviral therapy with interferon-α and ribavirin among study participants compared with standard clinical monitoring alone. BACKGROUND: Interferon-α is used to treat chronic hepatitis C. Interferons may induce adverse events that usually, but not always, reverse within a few days after the end of therapy. STUDY: Two hundred eleven patients with chronic hepatitis C, genotype 1b were treated with peginterferon and ribavirin for 48 weeks in a prospective trial. Two groups were randomly created. Group A was interviewed by a team of gastroenterologists, psychiatrists, and psychologists and treated with psychotherapy once a month. Group B was monitored once a month according to a conventional protocol that did not include psychotherapy. SVR (sustained viral response), severe psychiatric symptom onset, and mood progression were assessed (P calculated using Fisher exact test, Friedman test, Dunn posttest, and Mann-Whitney U-test). RESULTS: At baseline, there was no difference in depressive symptoms or liver histologic score between the 2 groups. The onset rate of severe psychiatric manifestations was 4.7% (Group A) and 16.1% (Group B) between the 24th and 36th weeks (P<0.01). Fifteen participants in Group A and 39 in Group B required antidepressants and benzodiazepines (P<0.05). CONCLUSIONS: Patients can develop depressive symptoms during interferon therapy. Multidisciplinary medical treatment with psychiatric counseling provided during the treatment of chronic hepatitis C may contribute to the decrease or prevent the higher rates of depression associated with interferon treatment.

Overview

Integrity signals

Registry

Crossref · 10.1097/mcg.0b013e3181d88af5

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Research works printed but not linked: 2

  1. 2006, 41th Annual meeting; International Consensus Conference on Hepatitis C. Consensus Statement., J Hepatol, 1, S56
  2. Hadziannis, 2004, Pegintron alpha 2-a and ribavirin combination therapy in chronic hepatitis C:a randomized study of treatment duration and ribavirin dose., Ann Intern Med, 140, 436

Cited by

See all 37

Metadata

Authors
Neri, S., Bertino, G., Petralia, A., Giancarlo, C., Rizzotto, A., Calvagno, G. S., Mauceri, B., Abate, G., Boemi, P., Di Pino, A., Ignaccolo, L., Vadalà, G., Misseri, M., Maiorca, D., Mastrosimone, G., Judica, A., & Palermo, F.
Affiliations
University of Catania (IT)
Venue
Journal of Clinical Gastroenterology
Published
2010-10
Volume
44
Issue
9
Pages
e210-e217
ISSN
0192-0790 (ISSN-L)
OpenAlex
W2330593897
Cited by
37
References
33
Citations by year
2024: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 7 · 2012: 8
FWCI
3.98
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
Keywords
chronic hepatitis C, pegylated interferon-alpha, ribavirin, psychiatric adverse effects, depression, psychiatric counseling, psychotherapy, multidisciplinary care, antidepressants, benzodiazepines, sustained virological response
MeSH terms
Interferon alpha-2, Antiviral Agents, Depression, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Polyethylene Glycols, Prospective Studies, Psychotherapy, Recombinant Proteins, Ribavirin, Severity of Illness Index, Interferon-alpha, Drug Monitoring, Hepatitis C, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin. https://app.cochat.ai/papers/10.1097/mcg.0b013e3181d88af5
The paper
Neri, S., Bertino, G., Petralia, A., Giancarlo, C., Rizzotto, A., Calvagno, G. S., Mauceri, B., Abate, G., Boemi, P., Di Pino, A., Ignaccolo, L., Vadalà, G., Misseri, M., Maiorca, D., Mastrosimone, G., Judica, A., & Palermo, F. (2010). A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0b013e3181d88af5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.